Abstract Body

Background

The prevalence of long‑COVID (LC) is estimated to be >30%, and proposed pathogenetic pathways include dysbiosis, immune dysregulation, and tissue damage, yet integrated insights are still lacking. Using a multi‑layered approach, we assessed epithelial damage, systemic microbial translocation (MT), microbiome alterations, and δγ T-cell dysfunction along the gut–lung axis.

Methods

Unvaccinated, hospitalized COVID-19 patients were enrolled during acute phase (T0) and classified at 3-month (T1) as having LC (LC+) or not (LC−). Plasma, whole blood and PBMCs were collected at both time points. Epithelial permeability and cell death (eCAD, CK-18/M65), gut and lung epithelial damage (IFABP, SPD), and MT (LBP) were assessed on plasma (ELISA). The microbiome profile was assessed with 16S rRNA gene sequencing on whole blood (NGS). γδ T-cells were isolated from PBMCs and characterized through multiparametric flow cytometry for phenotypes (Vδ1, Vδ2, HLA-DR, CD38, PD-1, CD103, CD3, CCR9, CD4, CD8, α4β7) and cytokines production upon PMA/IONO stimulation for functionality (TNF-α, IL-17, IFN-γ). A group of uninfected pre-pandemic subjects were included as controls (CTRLs).

Results

We enrolled 21 LC+ and 19 LC- matched for age, sex, and co-morbidities (Fig. 1A). During COVID-19, LC+ individuals showed significant higher CK-18, SPD and LBP versus LC- and CTRLs, whereas eCAD and IFABP were similar. Similar frequencies of Vδ1 and Vδ2 T-cells were observed among groups, however LC+ showed increased activated Vδ1 and Vδ2, decreased TNFα-producing Vδ1 (Fig. 1B) but similar IFN-γ and IL-2-producing cells, and decreased Vδ2 and Vδ1 with a gut-homing phenotype (α4β7+CCR9+), yet no differences in Vδ1 and Vδ2 with a lung-homing phenotype (α4β7-CCR9-CD103+). At follow-up, CK-18 and SPD remained elevated in LC+ whereas LBP normalized; eCAD remained stable, whereas IFABP increased overtime in both groups; γδ T-cells phenotypes and functionality normalized. Despite similar baseline microbiome composition in LC- and LC+, an enrichment of Oxalobacteraceae family was shown at T1 exclusively in LC+.

Conclusions

Individuals developing LC feature lung epithelial damage, MT, and γδ T cells dysfunction already during acute COVID-19. The persistence of lung injury, alongside progressive gut epithelial damage and enrichment of Oxalobacteraceae at 3 months from infection, suggests a role of gut-lung axis disruption in LC pathogenesis.

Table or Figure